- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Lenalidomide – November 2015
Lenalidomide: capsules, 5 mg, 10 mg, 15 mg, 25 mg, Revlimid®
Last updated
18 March 2016